NCT00494962已完成1 期
An Open-Label, Single-Dose, Randomized, 2-Period, Crossover, Bioequivalence Study Between Two 5-mg Tablets and a New 10-mg Tablet Formulation of Lecozotan SR in Healthy Subjects.
Wyeth is now a wholly owned subsidiary of Pfizer1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2007年6月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Pharmacokinetic (PK) analyses
研究概览
简要总结
To determine the bioequivalence between two 5-mg tablets of lecozotan and the new 10-mg tablet of lecozotan.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Generally healthy, man and women, aged 18 to 50 years.
排除标准
- •History or active presence of clinically important medical disease.
结局指标
主要结局
Pharmacokinetic (PK) analyses
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A Bioequivalence Study of Losartan Potassium Tablets (Containing Losartan Potassium 100 mg) in Normal, Healthy, Adults Under Fasting ConditionsHealthyNCT03459911Pharmtechnology LLC66
已完成
1 期
Fasted Bioequivalence Study of 2 Olanzapine Film-coated Tablets, 5 mg, in Healthy, Adult Male and Female Subjects.PharmacokineticsNCT05123976Joint Stock Company "Farmak"32
已完成
1 期
To Assess the Bioequivalence of Two Pacritinib Drug Product Formulations and FMI Formulation Following Oral Administration in Healthy SubjectsHealthyNCT02823171CTI BioPharma28
已完成
2 期
An Open-label, Randomized, 2-Period, Crossover, Pharmacokinetics StudyPregnancy PreventionNCT05360576Lupin Research Inc40
已完成
1 期
Study Evaluating Potential Pharmacokinetic (PK) Interaction Between Lecozotan and DigoxinAlzheimer DiseaseNCT00563732Wyeth is now a wholly owned subsidiary of Pfizer